50% off Premium Yearly

NYSE:IBM
This summary was created by AI, based on 24 opinions in the last 12 months.
IBM Common Stock, represented by the symbol IBM-N, has brought forward mixed sentiments among experts. While some express optimism over its long-term potential, particularly in AI and quantum computing, others highlight recent disappointing earnings and significant stock price drops. In terms of valuation, the stock trades at multiples ranging from 18x to 22x PE, leading to some experts suggesting it may be overvalued, especially considering its historical performance and recent volatility. Many experts also draw attention to its transition from hardware to services that could indicate a more sustainable business model. The overall sentiment suggests cautious optimism, with some experts advocating for buying during dips and others recommending to wait for clearer signals of recovery.
Boring, but now things are coming together. Left a lot of baggage behind with the spinoff, but kept Watson, a leader in AI applications in healthcare. Lot of horses that they haven't yet raced. 12-month price target of $257. Yield is 3%.
(Analysts’ price target is $191.36)Transitioning to more services. Has done all right. Trades at 16x. Has to prove it can grow double-digit earnings on a sustainable basis before it gets recognition from market, and this is harder for such a large company. Higher rates are impacting customers' budgets, seeing softness.
It's still inexpensive, still has upside at 22x PE.